Cancer therapy in Guilford, Connecticut

Medical Oncology & Hematology is a leading medical institution located at 669 Boston Post Road in Guilford, Connecticut, United States. Our dedicated team of doctors and healthcare professionals specialize in the treatment of cancer and blood disorders. We offer a comprehensive range of services including chemotherapy, radiation therapy, immunotherapy, and targeted therapy. Our goal is to provide personalized and compassionate care to each patient, supporting them through their journey to recovery. At Medical Oncology & Hematology, we are committed to excellence in healthcare and improving the lives of those affected by cancer and blood disorders.

Advanced Dermatology of Norwich is a leading institution located at 111 Salem Turnpike in Norwich, Connecticut, United States. We offer expert dermatological care for patients in Norwich, Guilford, and the surrounding areas. Our practice specializes in medical and surgical dermatology, Mohs surgery, phototherapy, and minor cosmetic dermatology procedures. Our team of skilled and experienced professionals is dedicated to providing compassionate care for a wide range of skin conditions. We strive to offer the most advanced and comprehensive dermatologic care available, ensuring that our patients receive the highest standard of care possible.

Lajos Pusztai is a renowned institution located at 111 Goose Lane, Guilford, Connecticut, United States. Dr. Pusztai is a Professor of Medicine at Yale University and serves as the Scientific Co-Director of the Breast Center, as well as the Co-Director of the Cancer Center Genomics, Genetics, and Epigenetics Program. With a medical degree from Semmelweis University of Medicine in Budapest and a D.Phil. degree from the University of Oxford in England, Dr. Pusztai's research group has made significant contributions to the understanding of different molecular, clinical, and epidemiological characteristics of estrogen receptor-positive and negative breast cancers. Dr. Pusztai has been a pioneer in utilizing gene expression profiling for predicting chemotherapy and endocrine therapy sensitivity, as well as developing bioinformatics tools for personalized treatment strategies. He is the principal investigator of several clinical trials investigating new drugs, including immunotherapies for breast cancer. With over 250 scientific manuscripts published in high-impact medical journals, Dr. Pusztai is recognized as one of the top 1% most highly cited clinical investigators in medicine. Additionally, he serves as an Associate Editor of the Journal of National Cancer Institute and is a member of the Scientific Advisory Board of the Breast Cancer Research Foundation.